Skip to content

Energy Metabolism in Branched-chain Organic Acidemias

Non-invasive Measurement of Energy Metabolism in Patients With Primary and Secondary Mitochondrial Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03917212
Enrollment
57
Registered
2019-04-16
Start date
2012-03-31
Completion date
2018-03-31
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Metabolism, Insulin Resistance, Metabolic Syndrome

Keywords

Organic acidemias, Mitochondria, Oxidative stress, Fatty liver, Dyslipidemia

Brief summary

Energy metabolism and insulin sensitivity were assessed in a case-control study in patients with branched-chain organic acidemias.

Detailed description

Children and adults with branched-chain organic acidemias and matched healthy humans underwent deep metabolic phenotyping using non-invasive magnetic resonance spectroscopy, oral glucose tolerance tests and measurements of leucocyte respirometry in order to assess changes in energy metabolism and insulin sensitivity.

Interventions

OTHERNo intervention

No intervention, observational study with metabolic characterisation

Sponsors

University Children's Hospital, Düsseldorf
CollaboratorUNKNOWN
German Diabetes Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* known branched-chain organic acidemia diagnosed by enzymatic or genetic test * age\>5 years

Exclusion criteria

* acute inflammatory conditions with fever, cold symptoms, gastro-intestinal infection within the last 24 hours * contraindications for an oral glucose tolerance test such as fasting blood glucose \>126 mg/dl, severe chronic gastrointestinal conditions, allergy against black currant * contraindications for magnetic resonance tomography (MRT) such as claustrophobia, metallic implants which are not MRT compatible

Design outcomes

Primary

MeasureTime frameDescription
Hepatic and skeletal muscle energy metabolismAt baselineHepatic and skeletal muscle energy metabolism assessed by magnetic resonance spectroscopy

Secondary

MeasureTime frameDescription
Insulin sensitivityAt baselineInsulin sensitivity measured from oral glucose tolerance test

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026